A detailed history of Brandes Investment Partners, LP transactions in Pfizer Inc stock. As of the latest transaction made, Brandes Investment Partners, LP holds 5,573,282 shares of PFE stock, worth $162 Million. This represents 2.02% of its overall portfolio holdings.

Number of Shares
5,573,282
Previous 5,056,568 10.22%
Holding current value
$162 Million
Previous $140 Million 11.13%
% of portfolio
2.02%
Previous 1.87%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 19, 2024

BUY
$25.26 - $29.6 $13.1 Million - $15.3 Million
516,714 Added 10.22%
5,573,282 $156 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $18.7 Million - $21.5 Million
721,719 Added 16.65%
5,056,568 $140 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $36 Million - $46.7 Million
1,377,426 Added 46.58%
4,334,849 $125 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $3.82 Million - $4.46 Million
119,009 Added 4.19%
2,957,423 $98.1 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $15.4 Million - $17.8 Million
426,855 Added 17.7%
2,838,414 $104 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $17 Million - $22.2 Million
431,989 Added 21.82%
2,411,559 $98.4 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $13.4 Million - $17.5 Million
-321,654 Reduced 13.98%
1,979,570 $101 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $1.31 Million - $1.59 Million
29,829 Added 1.31%
2,301,224 $101 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $55,417 - $65,707
1,191 Added 0.05%
2,271,395 $119 Million
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $4.53 Million - $5.61 Million
98,982 Added 4.56%
2,270,204 $118 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $9.63 Million - $14.3 Million
-232,982 Reduced 9.69%
2,171,222 $128 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $2.38 Million - $3.06 Million
60,616 Added 2.59%
2,404,204 $103 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $17.3 Million - $19.6 Million
480,678 Added 25.8%
2,343,588 $91.8 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $2.47 Million - $2.78 Million
73,613 Added 4.11%
1,862,910 $67.3 Million
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $529,160 - $672,873
-15,810 Reduced 0.88%
1,789,297 $65.7 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $7.27 Million - $8.53 Million
-228,892 Reduced 11.25%
1,805,107 $66.2 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $7.66 Million - $9.3 Million
-254,464 Reduced 11.12%
2,033,999 $66.5 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $803,088 - $1.15 Million
-29,711 Reduced 1.28%
2,288,463 $74.7 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $2.4 Million - $2.72 Million
-72,888 Reduced 3.05%
2,318,174 $90.8 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $3.77 Million - $4.88 Million
-115,888 Reduced 4.62%
2,391,062 $85.9 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $5.13 Million - $5.76 Million
-138,749 Reduced 5.24%
2,506,950 $109 Million
Q1 2019

May 10, 2019

SELL
$37.5 - $41.2 $14.9 Million - $16.4 Million
-396,922 Reduced 13.05%
2,645,699 $112 Million
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $11.4 Million - $13 Million
-297,382 Reduced 8.9%
3,042,621 $133 Million
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $2.86 Million - $3.47 Million
-83,059 Reduced 2.43%
3,340,003 $147 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $2.59 Million - $2.76 Million
-78,587 Reduced 2.24%
3,423,062 $124 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $6.56 Million - $7.61 Million
-205,630 Reduced 5.55%
3,501,649 $124 Million
Q4 2017

Feb 12, 2018

SELL
$33.26 - $35.29 $3.8 Million - $4.04 Million
-114,388 Reduced 2.99%
3,707,279 $134 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $118 Million - $131 Million
3,821,667
3,821,667 $166 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Brandes Investment Partners, LP Portfolio

Follow Brandes Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandes Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Brandes Investment Partners, LP with notifications on news.